Introduction
Specific peptide-derived glyoxal inhibitors have been shown to be potent inhibitors of the serine proteases [1] [2] [3] [4] [5] , the cysteine proteases [5] [6] [7] [8] and the aspartyl proteases [9, 10] . Glyoxal inhibitors are most effective with the cysteine proteases and their active site thiol group has been shown to form a thiohemiacetal with the glyoxal aldehyde group [6] . The aspartyl proteases bind the fully hydrated glyoxal, which mimics the tetrahedral intermediate thought to be formed during catalysis [9] . In the serine proteases the active site serine hydroxyl group has been shown to form a hemiketal with the keto-carbon of the glyoxal group, this hemiketal mimics the tetrahedral intermediate formed during catalysis [1, 2, 11] . In serine protease-glyoxal inhibitor complexes it has been shown that the pK a values of both the glyoxal hemiketal and hemiacetal hydroxyl groups have been reduced by 5-7 pK a units [1, 3] . The primary cause of the reductions in the pK a values of the hydroxyl-groups is thought to be due to the presence of the positively charged active site histidine [1, 3, 4, 12] .
In the metalloproteases an active site zinc atom is thought to play a similar role by lowering the pK a of the hydroxyl groups of a bound water molecule and by stabilizing the oxyanion of the catalytic tetrahedral intermediate [13] [14] [15] . As both the keto and aldehyde groups of the glyoxal group of peptide glyoxals are readily hydrated [1, 11] we expected that the hydroxyl groups of the hydrated glyoxal would be coordinated to the active site zinc atom of a metalloprotease such as stromelysin-1 (E.C. 3.4.24.17) . This coordination to the positively charged zinc atom should lower the pK a values of the hydroxyl groups of the hydrated glyoxal promoting the coordination of the oxyanion to the catalytic zinc and allowing the glyoxal group to function as an effective zinc binding group (ZBG).
Metalloprotease inhibitors can be classified as being designed to bind in the left hand side (P 3 -P 2 -P 1 -ZBG) or the right hand side (ZBG-P 1 '-P 2 '-P 3 ') of the active site or on both sides (P 3 -P 2 -P 1 -ZBG-P 1 '-P 2 '-P 3 '). Inhibitors binding on the right hand side of the active site are usually the most potent metalloprotease inhibitors [16] . Chemists biphenyl]-4-hexanoic acid (UK-370106-COOH) (Scheme 1) a potent right hand side inhibitor of the metalloprotease stromelysin-1 with a carboxylate zinc-binding group [17, 18] . We have converted the carboxyl zinc binding group of this inhibitor to a glyoxal group with 13 C-enrichment in the glyoxal aldehyde carbon (UK-370106-CO 13 CHO) . This allows us to use 13 C-NMR to determine whether there is oxyanion stabilisation within the stromelysin-1-UK-370106-CO 13 CHO inhibitor complexes and 1 H-NMR to determine if there are any low barrier hydrogen bonds present. Our catalytic and NMR studies at different pHs require that stromelysin-1 be stable during data acquisition. Therefore we have undertaken a study of the pH stability of stromelysin-1 to ensure that there is no significant irreversible denaturation during our experiments. In order to facilitate our NMR studies all this work has been carried out using the stromelysin-1 catalytic domain containing residues 83-247.
The stromelysins are metalloproteases which include stromelysin-1 (MMP-3), stromelysin-2 (MMP-10) and stromelysin-3 (MMP-11). Matrilysin (MMP-7) is closely related to the stromelysin-1 but it lacks its C-terminal domain and so it is similar to the C-terminal truncated stromelysin-1 (residues 83-247) examined in the present work [16] . As all these metalloproteases have similar active sites we would expect their catalytic domains to undergo similar interactions with glyoxal inhibitors. Therefore our studies with the stromelysin-1 catalytic domain (residues 83-247) should provide important insights into how glyoxal inhibitors interact with the stromelysins and similar metalloproteases such as matrilysin. However, with less closely related metalloproteases there may be significant differences in their interactions with glyoxal inhibitors. 
Materials and methods

2.1.Materials
NMR spectra of the (3R
The 1 H-NMR and 13 C-NMR spectra of this compound at 400 MHz have been reported but only the 1 H-NMR spectrum was partially assigned at 400MHz [17] . We have fully assigned both the 1 H-NMR and the 13 C-NMR spectrum at 500 MHz. 1 
Synthesis of UK-370106-CO 13 CHO
UK-370106-COOH was converted into UK 370106-CO 13 CHN 2 using a procedure modified from that described by Cesar at al. [19] . N-[ 13 C]Methyl-N-nitrosotoluene-p-sulfonamide was used to generate 13 The diazoketone (UK-370106-CO 13 CHN 2 ) was oxidised to the glyoxal using a procedure modified from that of Ihmels et al. [20] . 20 mg (0.034 mmol) of UK-370106-CO 13 to the 13 C-enriched glyoxal aldehyde carbon and its hydrate respectively. In water one signal at 90.4
ppm was observed due to the 13 C-enriched hydrated aldehyde carbon of the glyoxal group.
Isolation of the stromelysin-1 catalytic domain (residues 83-247).
The proMMP-3 catalytic domain complex was purified from E. coli (strain BL21(DE3)) that had been transformed with the pET-3A plasmid containing the gene for the proMMP-3 catalytic domain (residues 83-247). Cells were incubated at 37 o C to an optical density of A 590 = 0.4 -0.5 and induced with 0.4 mM isopropyl β-thio-galactoside and then incubated at 37 o C for 4 hours. The cells were centrifuged and suspended in 500 mL of 50 mM Tris-HCl buffer at pH 8 containing, 100 mM NaCl and 0.27 g/litre lysozyme. It was then stirred overnight at room temperature. 0.625 g of deoxycholate was added and the solution was stirred for 1-2 hours. 0.5 mL of DNase 1 (1 mg/mL) was added and the solution was stirred for 1-2 hours. The solution was centrifuged and the pellet was washed three times with 50 mM Tris-HCl at pH 8 containing 100 mM NaCl and 0.5% (v/v) Triton-X100.
The pellet was dissolved in 20 mM Tris-HCl buffer at pH 8. 
Catalytic activity and inhibition of SCD
The catalytic activity of SCD was determined by its ability to catalyze the hydrolysis of the thiopeptolide Acetyl-Proline-Leucine-Glycine-[2-mercapto-4-methyl-pentanoyl]-Leucine-Glycine-OC 2 H 5 that was developed for assaying collagenase activity [22] . A 1000 µl assay contained 50 mM MOPS buffer at pH 6.0, 10 mM CaCl 2 , 100 µM thiopeptolide substrate, 1 mM 5, 
Concentrations of SCD
Enzyme concentrations were determined using the ε 280 value of 28700 M -1 cm -1 determined in the Results section.
NMR Spectroscopy
NMR spectra at 11.75 T were recorded with a Bruker Avance DRX 500 standard-bore spectrometer operating at 125.7716 MHz for 13 C-nuclei. 5 mm-diameter Shigemi NMR tubes containing 0.32-0.34 mL samples were used for 13 used which was reduced to 0.006 watts during the relaxation delay to minimize dielectric heating but maintain the Nuclear Overhauser Effect. Unless stated otherwise all spectra were transformed using an exponential weight factor of 20 Hz.
Results
Properties of the Stromelysin-1 catalytic domain 83-247
The protein concentration of the unfolded stromelysin-1 catalytic domain 83-247 in 6 M guanidine hydrochloride containing 0.02 M phosphate buffer at pH 6.5 was estimated using an ε 280 value of 27310 M -1 cm -1 calculated from the expected extinctions of the 3 tryptophan and 8 tyrosine residues [28] of the stromelysin-1 catalytic domain 83-247. This extinction was use to determine the concentration of a sample of the active SCD when it was dissolved in 6 M guanidine hydrochloride containing 0.02M phosphate buffer at pH 6.5. By measuring absorbance of the same amount of the active stromelysin-1 catalytic domain 83-247 in water at pH 7.5 we estimate that in water at pH 7.5
the native stromelysin-1 catalytic domain 83-247 has an ε 280 value of 28700 ± 900 M -1 cm -1 (Mean of 6 determinations). This is in good agreement with the values of 28790 and 28460 M -1 cm -1 determined previously [29, 30] for the stromelysin-1 catalytic domain containing the residues 83-256. As both these catalytic domains contain the same number of tryptophan, tyrosine and cysteine residues they are expected to have the same extinction coefficients at 280 nM [28] . When SCD was assayed using the thiopeptolide substrate Ac-Pro-leu-Gly-thioester-Leu-Leu-Gly-OC 2 H 5 at 25˚C and pH 6.0 the estimated catalytic parameters k cat and K M were 2.60 ± 0.13 s -1 and 395 ± 54 μM respectively. These values are in reasonable agreement with earlier values obtained for k cat and K M respectively for full length stromelysin-1 and for the stromelysin-1 catalytic domain 83-256 ( Table 1 ). The stoichiometry of the 13 C-NMR titration of SCD with UK-370106-CO 13 CHO confirmed that our SCD preparations were fully active. Stability of the stromelysin-1 catalytic domain at pH 7.5.
13 C-NMR of the UK-370106-CO 13 CHO inhibitor in d 6 -dimethyl sulfoxide and aqueous solutions
In 10 mM MOPS buffer at pH 7.5 containing 10 mM CaCl2 the enzyme lost 40% of its catalytic activity after freezing and thawing, repeating the process results in the original catalytic activity being reduced by 70%. Therefore we did not freeze stromelysin-1 solutions. At 4 ˚C stromelysin-1 retained 95% of its catalytic activity after 102 days. Therefore the enzymes was stored at 4 ˚C before being used. There was an initial 6-9% decrease in activity at pHs 6.0 ( Fig. 1A ) and 8.4 ( Fig. 1B ) but then the catalytic activity was stable. At pH 5.5 there was an initial 6% decrease in catalytic activity followed by a linear decrease in catalytic activity (Fig. 1A) . There was an exponential decrease in catalytic activity at pH values of 5 ( Fig.3A ) and 9 ( Fig. 1B) . At pHs 4.5 ( Fig. 1A ) and 10.0 (Fig. 1B ) the decrease in activity was biphasic there was rapid exponential loss of the first 60-66% of catalytic activity but after that the exponential decrease in catalytic activity was 10-40 times slower.
At pHs 6-8 SCD samples lost less than 10 % of their catalytic activity in 960 min ( Fig. 1   A,B) . In order to observe the 13 C-NMR signal from the 13 C-enriched carbon of UK-370106-CO 13 CHO bound to SCD, NMR spectra were accumulated over a 54 minute period. After 1 hour at pH 5.5 SCD samples retained 90% of their catalytic activity but at pH 5.0 only 36% of their catalytic activity was retained after 1 hour (Fig. 1A) . Therefore our NMR studies were restricted to pH values of 5.5 or higher ( Fig.s 4 & 5) . After 1 hour at pH 8.4 SCD samples retained 89% of their catalytic activity but at pH 9.0 only 52 % of their catalytic activity remained after one hour (Fig. 1B) .
Therefore our NMR studies were restricted to pH values of 8.4 or less ( Fig.s 4 & 5) . For initial rate measurements at pHs 5-9 there was no detactable loss of catalytic activity over a 5 minute period.
However at pH 4.5 initial rates were measured over a 2 minute period during which there was no more than a 10% loss of catalytic activity. The rapid rate of acid denaturation at pH 4 and below prevented studies at pH 4 or lower.
Effect of pH on the binding of UK-370106-CO 13 CHO to SCD
K i values were minimal at pHs 5.5-6.5 but increased at lower or higher pHs ( Fig. 2A) . A plot of 1/K i versus pH (Fig. 2B) was bell shaped and the fitted pK a values were 5.9 ± 0.4 and 6.2 ± 0.4 for pK 1 and pK 2 respectively. These free enzyme pK a values are very similar to the values of 5.4-5.8 and 6.0-6.3 obtained from plots of 1/K i versus pH with other inhibitors [32] . Plots of k cat /K M versus pH give similar free enzyme pK a values for pK 1 and pK 2 and they also give an additional pK a of 8.5-9.9 [32, 33] . From the pH dependence of the K i values ( Fig. 2A) it was estimated the increases in K i at acid and alkaline pHs depended on pK a values of 4.4 ± 1.5 and 7.5 ± 0.2 respectively. Due to the large error associated with the value of pK 1 (4.4 ± 1.5) obtained from the pH dependence of K i we do not know if pK 1 is significantly perturbed by inhibitor binding. The pK a of 7.5 suggests that inhibitor binding increases pK 2 by 1.3 pK a units.
13 C-NMR of SCD inhibited by UK-370106-CO 13 CHO
On adding UK-370106-CO 13 CHO (Fig. 3b) to SCD (Fig. 3a ) at pH 7.0 a new signal at 92.0 ppm was detected ( Fig. 3c ). Carbons with directly bonded protons relax predominantly by dipolar relaxation and linewidths are directly proportional to M r values provided the carbon is rigidly bound [34, 35] .
When the fully hydrated inhibitor (Structure (a) in Scheme 2, M r 620) binds to the SCD (83-247, M r 18575) we expect an increase in linewidth of 20-35 Hz [34, 36] . The observed increase in linewidth was 20 ± 7 Hz confirming that the UK-370106-CO 13 CHO inhibitor is tightly bound to SCD. The chemical shift value of 92.0 ppm confirms that the inhibitor glyoxal aldehyde carbon is sp 3 hybridised and therefore the glyoxal aldehyde group must be fully hydrated when it is bound to SCD. The UK-370106-COOH is a potent inhibitor of SCD (Table 2 ) and so it should displace the less tightly bound glyoxal inhibitor UK-370106-COCHO inhibitor ( Table 2) . Adding approximately equimolar UK-370106-COOH led to loss of the signal at 92.0 ppm due to the bound glyoxal inhibitor and re-appearance of the signal at 90.4 ppm due to the free glyoxal inhibitor (Fig. 3d ). This confirms that the glyoxal inhibitor is reversibly bound at the active site of SCD.
Effect of pH on the 13 C-NMR signal from the 13 C-enriched carbon of UK-370106-CO 13 CHO inhibitor bound to SCD
The chemical shift of the signal due to the 13 C-enriched carbon of the bound inhibitor did not change significantly from pH 5.52 to 8.44 (only changed 0.1 ppm, Fig. 4 ). However, the intensity of this signal changed significantly with pH ( Fig. 4) and showed a bell shaped pH dependence ( Fig. 5 ) with signal intensity increasing according to a pK a of 5.8± 0.2 to a maximum value at pH 6.75 then decreasing in intensity according to a pK a of 7.8 ± 0.2 at alkaline pHs .
Based on the experimentally determined K i value of 0.81 μM at pH 5.53 we estimate that 99.4% of SCD will be saturated with the glyoxal inhibitor at this pH. This, plus the fact that no free inhibitor signals at 90 .4 ppm were detected at low pH, confirms that the decrease in signal intensity at low pH ( Fig.s 4 & 5) cannot be attributed to the disassociation of the SCD-UK-370106-CO 13 CHO inhibitor complex. The pK a of 7.8 ± 0.2 for the decrease in signal intensity at alkaline pH values is very similar to the pK a of 7.6 ± 0.2 for the increase in K i values at alkaline pHs (Fig. 2a ). This suggests that the decrease in the intensity of the signal from the UK-370106-CO 13 CHO inhibitor bound to SCD is due to the disassociation of the inhibitor complex at alkaline pHs. This was confirmed by the fact that the release of free inhibitor at 90.41 ppm was observed at alkaline pHs ( Fig. 4e, f) . Both bound and free inhibitor were observed in our 13 C-NMR experiments at pHs 7.54 ( Fig. 4e ) and 7.96 (Fig. 4f ). These signals were lost at higher pHs ( Fig. 4g ) due to breakdown of the free glyoxal inhibitor at high pH [1] . The fact that we can observe clearly resolved signals from both the free (90.4 ppm) and bound (~92.0 ppm) inhibitor when the K i is approx. 20 μM shows that the rate of association of SCD and the UK-370106-CO 13 CHO inhibitor must be no greater than 2 x 10 6 M -1 . s -1 at pHs 7.5-8.0. If the rate of association were 2 x 10 7 M -1 . s -1 the signals due to the free and bound inhibitor would coalesce and a single signal would be observed.
1 H-NMR of the hydrogen-bonded protons of SCD, a SCD-UK-370106-COOH complex, and a SCD-UK-370106-CO 13 CHO complex
Hydrogen bonded protons have chemical shifts in the range 11-22 ppm and with SCD 7 signals were observed with chemical shifts > 11 ppm (Fig. 6A ). These signals had chemical shifts of 11.4, 11.6, 11.8, 12.3, 12.9, 13.1 and 13.5 ppm (Fig. 6A ). As the pH increased the intensity of the signals at 12.9, 13.1 and 13.5 decreased ( Fig.s 6A , spectra 1-6) but these intensities were restored when the pH was lowered to pH 6.7 (spectrum not shown). As the positions of the signals did not change with pH, this decrease in intensity must be controlled by a slow exchange process. The pK a values of 7.94, 6.67 and 7.49 controlling the decrease in intensity of the signals at 12.9, 13.1 and 13.5 ppm respectively (Table 3) , are significantly larger than pK 1 (5.4-5.8) and pK 2 (6.0-6.3) and smaller than pK 3 (8.5-9.9) determined from the pH dependence of k cat /K M [32, 33] . It is therefore unlikely that these hydrogen bonded protons play a direct role in catalysis. On binding the UK-370106-COOH ( Fig. 6B) or UK-370106-CO 13 CHO (Fig. 6C) inhibitors the signal at 12.9 ppm was no longer resolved. However the intensity of the signal at 13.1 increased suggesting these signals may have merged.
On adding UK-370106-COOH a new signal at 12.1 ppm was resolved (Fig. 6B, spectrum 4 ).
This signal was not observed when the UK-370106-CO 13 CHO inhibitor was added to SCD and so it would appear to represent a unique hydrogen bond formed between SCD and the UK-370106-COOH inhibitor. However, we cannot dismiss the possibility that this signal is present in the free enzyme and glyoxal complex but it is merged with other signals and only when the UK-370106-COOH inhibitor binds is the signal at 12.1 ppm resolved. The signal at 11.6 in SCD (Fig. 6A , spectrum 2) and in the SCD-UK-370106-COOH inhibitor complex ( Fig. 6B , spectrum 2) was not resolved when the UK-370106-CO 13 CHO inhibitor was added to SCD ( Fig. 6C ) which may simply reflect the fact that it may have merged with signal at 11.4 ppm. The binding of inhibitors to SCD increased the pK a values controlling the intensity of the signal at 13.1 ppm (Table 3 ). If the binding of the inhibitors increases the hydrophobicity of the environment of the ionizing group then this increase in pK a would suggest that the ionizing group controlling the intensity of the signal at 13.1 ppm is a neutral acid such as a carboxylate group. As inhibitor binding causes the pK a controlling the intensity of the signal at 13.5 ppm to stay the same or decrease then this suggests that the ionizing group controlling the intensity of the signal at 13.5 ppm is a cationic acid such as the imidazolium group of a histidine residue.
Strongly hydrogen bonded protons have chemical shifts of 16-20 ppm and are called lowbarrier hydrogen bonds [37] . It is clear from our results that there are no low barrier hydrogen bonds in SCD ( Fig. 6A ) and none are formed when SCD binds the UK-370106-COOH (Fig. 6B) or UK-370106-CO 13 CHO (Fig. 6C) inhibitors.
Discussion
For most metalloproteinases the pH dependence of k cat /K M is bell shaped being dependant on three protonic states (EH 2 , EH and E) with the EH state being the catalytically active form (Scheme 3A) whose formation is governed by pK 1 and whose breakdown is governed by pK 2 [38] . However, for SCD the pH dependance of k cat /K M is more complex [32, 33, 38] being dependent on 4 protonic states (EH 3 , EH 2 , EH and E) with two catalytically active states (EH 2 and EH) whose formation and breakdown are controlled by the free enzyme pK a s pK 1 , pK 2 and pK 3 (Scheme 3B). pK 1 , pK 2 and pK 3
give free enzyme pK a values of 5.2-5.8, 6.0-6.3 and 8.7-9.9 respectively [32, 33, 38] . pK 1 has been assigned to a Glu-202-zinc-water complex [32, 33, 38] and pK 3 is assigned to Tyr-223 [38] . Using site directed mutagenesis pK 2 has been shown to be due to His-224 which is thought to stabilize the enzyme structure by hydrogen bonding to a main chain peptide carbonyl group [32, 38] .
Replacement of His-224 with a glutamine residue increases catalytic activity and gives a bell shaped pH profile for k cat /K M showing that ionisation of His-224 decreases catalytic activity [38] . Therefore only pK 1 is thought to be directly involved in catalysis while pK 2 controls deprotonation of His-224 by reducing but not eliminating catalytic activity, pK 3 controls deprotonation of Tyr-223 which eliminates catalytic activity. In both cases (pK 2 and pK 3 ) deprotonation is thought to cause conformational changes that reduce catalytic activity.
The binding of inhibitors is dependent on both pK 1 and pK 2 [32] . These studies [32] Our studies with the fluorescent substrate MCA-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH 2 were not subject to these limitations and were only limited by the pH stability of SCD and so could be extended to pH 4.5-9 for catalytic measurements. In free SCD pK 1 reflects ionization of the bound water in the Glu-202-zinc-water complex. However, when the UK-370106-CO 13 CHO inhibitor is bound we expected that the zinc bound water would be replaced by the inhibitor glyoxal group. The hydroxyl groups of the glyoxal hemiacetal and hemiketal groups are less basic than water by 3.5-6 pK a units [1, 3] and so would be expected to have pK a values 3.5-6.0 pK a units lower than 5.9 (pK 1 ) when bound to zinc and so we would expect the glyoxal hemiacetal hydroxyl groups to be fully ionised at pHs 5.5-8.5 if they are coordinated to the active site zinc. However, at pH 5.5-8.5 the hemiacetal carbon of the inhibitor glyoxal group has a chemical shift of 91.89-91.99 ppm (Fig. 4) .
When glyoxal inhibitors are bound to chymotrypsin ionisation of the glyoxal hemiacetal hydroxyl groups in the presence of the positively charged active site histidine residue produces a titration shift from ~91 to ~97 ppm [1, 4] . Similar titration shifts are therefore expected if the positively charged active site zinc is coordinated to the glyoxal hemiacetal hydroxyl groups. The observed chemical shifts of ~92 ppm (Fig. 4) show that the inhibitor glyoxal hemiacetal hydroxyl groups are not ionised when bound to SCD at pHs 5.52-8.44. Therefore we conclude that we have found no evidence that glyoxal hemiacetal hydroxyl groups are directly coordinated to the active site zinc atom.
If the glyoxal hemiketal hydroxyl groups are coordinated to the active site zinc of stromelysin-1 then the increase in intensity of the signal at 92 ppm with a pKa ~5.8 (Fig. 5 ) could reflect the binding/ionisation of the glyoxal hemiketal hydroxyl groups when the glyoxal inhibitor binds to stromelysin-1. Ionisation of the hydroxyl groups of the glyoxal hemiketal group are expected to produce titration shifts of ~1.88 ppm (2 x 0.94 ppm, [3] ) at the glyoxal hemiacetal carbon. If we assume fast exchange and a titration shift of 90.12 to 92 ppm controlled by a pK a of 5.8 then a titration shift of 1.25 ppm would be observed from pH 5.5 to 8.5. The observed titration shift of 0.1 ppm (91.89-91.99) from pH 5.55 to 8.44 (Fig. 4) is negligible and so we cannot assign the pK a of 5.8 (Fig. 5) to ionisation of the glyoxal hemiketal hydroxyl groups by fast exchange. If ionisation of the glyoxal hemiketal hydroxyl groups was a slow exchange process then we should have observed a signal at ~90.1 at low pH whose intensity would decrease according to a pK a of 5.8
as there was a concommittant increase in the intensity of the signal at 92 ppm also according to a pK a of 5.8. No additional signal at ~90.1 ppm was observed at low pH (Fig. 4) confirming that the pK a of 5.8 does not reflect the ionisation of the glyoxal hemiketal hydroxyl groups. The pK a values of glyoxal hemiketal hydroxyl groups are about 5-6 pK a units lower than the pK a of the hydroxyl group of water [1, 3] . Therefore if the hemiketal hydroxyl groups interact with active site zinc atom in the same way as the hydroxyl group of water then we would expect that the glyoxal hemiketal hydroxyl groups would have a pK a value of 2.4 or less and so it is possible that the glyoxal hemiketal hydroxyl groups are ionised and coordinated to the active site zinc atom. However, if the glyoxal group was coordinated to the zinc atom we would expect the glyoxal hemiacetal hydroxyl groups to also be ionised with the hemiacetal carbon having a chemical shift of ~97 ppm which is not observed. We have also shown that when a glyoxal inhibitor binds to pepsin there is an increase in chemical shift of the glyoxal hemiacetal carbon from 89.8 to 90.9 even though both the hemiacetal and hemiketal hydroxyl groups are not ionised in the free and bound glyoxal [9] . The increase in chemical shift of the glyoxal hemiacetal carbon from 90.4 to 92.0 ppm on binding the UK-370106-CO 13 CHO inhibitor to SCD is similar in magnitude and can be attributed to the difference in the environment of the free and bound species.
Therefore all our experimental evidence suggests that the inhibitor glyoxal group is not directly coordinated to the catalytic zinc atom. The fact that the glyoxal inhibitor is a 500-fold weaker inhibitor than its parent carboxylate inhibitor supports this interpretation.Therefore we propose that the glyoxal inhibitor has not displaced the active site water molecule. In this case the pK a of 5.8
reflects ionisation of this water molecule and binding of the glyoxal inhibitor has not significantly perturbed pK 1 from its expected value of 5.4-5.8 in free SCD [32] . pK 2 is assigned to His-224 which in its protonated form is thought to stabilise the S 1 ' subsite of SCD by hydrogen bonding to a peptide carbonyl group [32, 38] . As histidine is a cationic acid its pK a is not expected to be affected by the changes in the hydrophobicity of its environment due to inhibitor binding. However on binding the UK-370106-CO 13 CHO inhibitor, pK 2 is raised from 6.2 to 7.5. This suggests that this pK a is not due to a cationic group such as the imidazolium group of His-224. However, increases in histidine pK a values on ligand binding are observed in the serine proteases [4] when the imidazolium ion forms an ion pair with a carboxylate group. Therefore the increase in pK 2 suggests that on binding the UK-370106-CO 13 CHO inhibitor the interaction of histidine-224 with a negatively charged group is enhanced. The alternative possibility that the pK a of 7.5 is due to pK 3 being lowered also requires that pK 2 be suppressed which we consider unlikely. pK 3 is due to the hydroxyl group of the tyrosine-223 residue and as it is a neutral acid its pK a is expected to increase if binding of a ligand increases the hydrophobicity of its environment. It is therefore unlikely that pK 3 has decreased to 7.5 on inhibitor binding as this would be expected to increase the hydrophobicity of its environment and so increase its pK a . Therefore we assign the pK a of 7.5 to pK 2 .
The association rate constant for glyoxal inhibitors binding to the serine proteases has been shown to be at least 100 x slower than the diffusion controlled rate constant of 10 8 M -1 s -1 [2, 4, 12] .
These slow association rate constants are expected because inhibition of the serine proteases by glyoxal inhibitors involves the reversible formation of a hemiketal adduct between the active site serine hydroxyl group and the keto-carbon of the inhibitor glyoxal group [1] . However, it is surprising that with the aspartyl protease pepsin [9] and with the metalloprotease SCD the association rate constant of glyoxal inhibitors is also at least a 50 x slower than the diffusion controlled rate constant. Hydration and dehydration of carbonyl groups is a slow process [39] . The peptide glyoxal inhibitor is bound to the the aspartyl protease pepsin in its fully hydrated form and so the slow association rate in this case may be due to the slow rate of hydration of the glyoxal ketocarbon. Likewise with SCD the slow association rate could reflect the slow rate of hydration or dehydration of the glyoxal inhibitor. Our NMR results with SCD and the UK-370106-CO 13 CHO inhibitor show that the glyoxal aldehyde carbon is fully hydrated in both the free and the bound inhibitor. Therefore if association involves a slow hydration-dehydration step then this must be at the glyoxal keto-carbon. If, as we argued, the free UK-370106-CO 13 CHO inhibitor is fully hydrated in water then this suggests that the keto-carbon of the glyoxal inhibitor might be dehydrated when it is bound to SCD. It is also possible that the slow association rate could be because inhibitor binding involves a slow conformational change as has been observed with inhibitors binding to other metalloproteinases such as the gelatinases [40] .
Prostromelysin-1 is a 57 kDa protein which is activated by removal of 82 amino acid residues from the N-terminus by proteolysis. This produces catalyically active 45 kDa stromelysin-1 containig residues 83-477 [21] . It has been reported [33] that at 25 °C stromelysin-1 (residues 83-477) retains full catalytic activity for 15 hours at pHs 5.5 to 9.5. For stromelysin-1 C-terminal truncated stromelysin-1(residues 83-255) at 37 °C it has been shown that after an initial ~20% decrease in catalytic activity the enzyme is stable at pHs 6-9 for at least 6 hours [41] . The C-terminal truncated stromelysin-1 (residues 83 to 247) used in this work was stable at 25 °C for at least 16 hours from pH 6 to pH 8.4 (Figs.1A,B ). Therefore we conclude that at 25 °C , C-terminal truncation decreases the stability of the stromelysin-1 catalytic domain at pH values > 8.4 and < 6.0. However, the active truncated enzyme has essentially the same catalytic properties as the non-truncated enzyme. Fig. 3 . 13 C-NMR spectra of [1-13 C]UK 370106-CO 13 CHO before and after addition to SCD at pH 7.
Scheme legends
Figure legends
Acquisition and processing parameters were as described in the "Experimental Procedures". Sample Acquisition and processing parameters were as described in the "Experimental Procedures". Sample respectively. Also 10 and 40 μl of 1M glycine at pH 9.8 were added to samples 5 and 6 respectively. CHO 7.07 ±0.10 7.02 ±0.12 a The pK a values were obtained by fitting intensities of the appropriate signals at the pH values given in Fig. 5 to the equation I obs =I max /(1+K a /[H]). 
